Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report벤다무스틴과 리툭시맙 치료 후 중증급성호흡기증후군 코로나바이러스 2의 지속적인 바이러스 배출: 증례 보고Case Reports Published on 2022-06-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Admission Bendamustine Case report Chain Reaction Chemotherapy chemotherapy session chronic disease Chronic diseases condition coronavirus coronavirus disease COVID-19 detectable discharged eight FIVE follicular Follicular lymphoma hospital initiated lymphopenia N501Y nasopharyngeal specimen nine NPs on admission Patient patients persistent persistent infection polymerase chain polymerase chain reaction positive receive receiving respiratory rituximab RNA SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 tested the patient the SARS-CoV-2 therapy Treatment variant Viral viral shedding [DOI] 10.1016/j.jiac.2022.01.014 PMC 바로가기 [Article Type] Case Reports
Evaluation of a Wastewater-Based Epidemiological Approach to Estimate the Prevalence of SARS-CoV-2 Infections and the Detection of Viral Variants in Disparate Oregon Communities at City and Neighborhood ScalesSARS-CoV-2 감염의 유병률을 추정하기 위한 폐수 기반 역학 접근 방식 평가 및 도시 및 인근 지역 규모의 이질적인 오레곤 커뮤니티에서 바이러스 변이체 감지Article Published on 2022-06-012022-09-11 Journal: Environmental health perspectives [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] addition Affect Analysis Asymptomatic Asymptomatic cases authority B.1 city clinically communicable Community Concentration correlated correlation COVID-19 demography detection disease disparate door eight Epidemiology estimate Estimated event examined greater Health authority hotspot identify indicated Infection infections location log nasal swab neighborhood Pearson positive positive correlations Prevalence Previous studies previous study public health quantified Quantitative R 2 Randomized ranged reliability reported SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 variant SARS-CoV-2 variants scalability scale sequenced significantly Surveillance tested Treatment Variation variations wastewater [DOI] 10.1289/EHP10289 PMC 바로가기 [Article Type] Article
Neuromuscular complications after COVID-19 vaccination: a series of eight patients코로나19 예방접종 후 신경근 합병증: 8명의 환자 연속Case Reports Published on 2022-06-012022-09-11 Journal: Acta neurologica Belgica [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 association brachial can not Care Case series case sery causal relationship chronic inflammatory demyelinating polyneuropathy CIDP classical collected Complication Coronavirus-2 COVID-19 COVID-19 vaccination COVID-19 vaccine disorder eight Epidemiological study etiology Guillain-Barré Guillain-barrè syndrome Immune-mediated include Infection Inflammatory limbs neurologic Neuromuscular one patient paresthesia Patient phenotype Phenotypes Polyneuropathy receiving reported SARS-CoV-2 second dose secondary care syndrome the vaccine two patients vaccination Vaccine variant weakness with COVID-19 [DOI] 10.1007/s13760-022-01941-0 PMC 바로가기 [Article Type] Case Reports
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects다발성 경화증 환자에서 SARS-CoV-2 체액 반응의 장기간 지속Article Published on 2022-06-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus age anti-Spike IgG anti-spike IgG levels appearance benefit BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine BNT162b2-mRNA vaccine booster booster vaccination booster vaccinations Cladribine Cohort comparable coronavirus Coronavirus-19 dimethyl fumarate Disease modifying therapies dose eight evaluated faster fingolimod Fingolimod- Glatiramer Glatiramer acetate groups healthy control healthy controls humoral humoral immune response Humoral persistence Humoral response IgG IgG levels interferon long term mRNA vaccine Multiple multiple sclerosis Natalizumab Ocrelizumab pandemic Patient patients persistence receiving regimen respiratory SARS-CoV-2 SARS-CoV-2 BNT162b2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike protein severe acute respiratory syndrome Coronavirus spike Spike protein subject subjects Teriflunomide the SARS-CoV-2 titre variants [DOI] 10.1016/j.msard.2022.103800 PMC 바로가기 [Article Type] Article
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy Research Published on 2022-06-012022-10-05 Journal: Nature cancer [Category] 임상, 진단, 치료기술, 치료법, [키워드] 95% CI absence Adverse adverse event analyzed Cancer Cancer immunotherapy Cancer therapy clinically Cohort cohort study common condition COVID-19 vaccination COVID-19 vaccines CRS CXCL8 cytokine level Cytokine release syndrome Cytokines Diagnosis eight elevated event Hospitalized immune immune response immune-checkpoint inhibitor interleukin-6 modulate observé occurred Patient patients died receive response Serious Adverse Event serum serum cytokine single-center Symptoms therapy Treatment Tumor upregulated vaccination [DOI] 10.1038/s43018-022-00398-7 [Article Type] Research
PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab togetherPK/PD 모델링은 밤라니비맙 단독 또는 밤라니비맙과 에테세비맙을 함께 치료한 후 환자의 SARS-CoV-2 바이러스 부하 감소와 COVID-19 관련 임상 증상의 가속화된 해결을 연결합니다.Clinical Trial Published on 2022-06-012022-09-12 Journal: CPT: pharmacometrics & systems pharmacology [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] accelerated administration bamlanivimab baseline characterized clinical symptom clinical trial coronavirus disease Course COVID-19 COVID-19-related symptom COVID-19-related symptoms decrease demonstrated develop disease driven by Effect eight etesevimab faster Immunity in viral indicated Mild modeling moderate neutralizing monoclonal antibody offer onset of symptoms participant passive immunity Patient patients with COVID-19 Placebo Probability Receptor binding domain reduction in resulting SARS-CoV-2 SARS-CoV-2 viral load severity of symptom statistically significant Symptom symptom resolution symptom severity the spike protein Treatment Viral load viral load reduction while with COVID-19 [DOI] 10.1002/psp4.12784 PMC 바로가기 [Article Type] Clinical Trial
Risk-based Decision Making Related to Pre-Procedural-COVID-19 Testing in the Setting of Gastrointestinal Endoscopy: Management of Risks, Evidence, and Behavioral Health EconomicsResearch article Published on 2022-06-012022-10-05 Journal: Gastrointestinal endoscopy [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] adjusted age approach assist Asymptomatic carriers asymptomatic patients Australian Therapeutic Goods Administration benefit chain Clinicians Cohort community transmission COVID-19 infection COVID-19 testing COVID-19 transmission death Decision making develop diagnostic economics eight expected Factor Gastrointestinal guideline HCW HCWHealth Care Worker Health care worker identify Infection occur organizations Outpatient PCR PCRpolymerase chain reaction Personal protective equipment polymerase chain reaction PPE PPEpersonal protective equipment Prevalence Prevent Probability proportion provide QALYQuality Adjusted Life Year Quality Adjusted Life Year Rapid rapid antigen test RATRapid Antigen Test reaction real time real time Polymerase Chain Reaction reduce reduced reductions in respond Result resulting risk risk of transmission risk reduction RT-PCRreal time Polymerase Chain Reaction SAE SAEs SAESerious Adverse Event SARS-CoV-2 SARS-COV-2 infection sensitivity Serious Adverse Event setting Support Test tested Testing TGAAustralian Therapeutic Goods Administration the patient the SARS-CoV-2 therapeutic vaccination rate variable variant was used [DOI] 10.1016/j.gie.2022.05.023 [Article Type] Research article
A global report on the dynamics of COVID-19 with quarantine and hospitalization: A fractional order model with non-local kernelResearch article Published on 2022-06-012022-10-05 Journal: Computational biology and chemistry [Category] 유전자 메커니즘, [키워드] ABC America Americas Analysis Asia Asymptomatic Atangana-Baleanu (ABC) Fractional Derivative basic reproduction number calculated classical COVID-19 decrease Disease Free Equilibrium eight Endemic Endemic Equilibrium Europe high risk Hospitalized individuals infected individual Infection infection rate mathematical MATLAB parameter parameters predicted quarantine rate of infection reduce reported shown Spread susceptible symptomatic Treatment Variation was obtained [DOI] 10.1016/j.compbiolchem.2022.107645 [Article Type] Research article
Protecting the mental and physical well-being of frontline health care workers during COVID-19: Study protocol of a cluster randomized controlled trialCOVID-19 기간 동안 최전선 의료 종사자의 정신적, 육체적 웰빙 보호: 클러스터 무작위 통제 시험의 연구 프로토콜Article Published on 2022-06-012022-09-11 Journal: Contemporary clinical trials [Category] COVID19(2023년), SARS, 임상, [키워드] acceptability addition AID anxiety symptoms assigned Burnout Cluster Controlled trial COVID-19 COVID-19 pandemic Depression disorder distress Effectiveness eight Evidence feasibility first aid HCW Health care Health care worker health care workers health center Healthcare workers hospital implementation include initial Injury Intervention Mental mental health Moral distress pandemic physical Posttraumatic Stress posttraumatic stress disorder Primary outcome Primary outcomes problems Protecting protocol Psychological Psychological distress Randomized controlled trial Randomly recruit Resilience Result risk secondary outcome Secondary outcomes selected Stress Support turn usual care Well-being [DOI] 10.1016/j.cct.2022.106768 PMC 바로가기 [Article Type] Article
Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine인도에서 여행하는 41명의 학생 그룹에서 SARS-CoV-2 Delta 변종 감염의 두 개별 클러스터: 엄격한 테스트 및 검역의 필요성에 대한 예시Article Published on 2022-05-312022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] affecting Antigen B.1.617.2 Belgium Cluster communicable communicable disease Communicable disease control community transmission Contact tracing contribute country COVID-19 decrease Delta delta variant disease disease control eight Extensive Follow-up France Genome sequencing genomic group highlight illustration India Infection infections measure New outbreak Paris Prevent quarantine quarantine measures remained repeated reported SARS-CoV-2 SARS-CoV-2 variants Separate Sequencing severe symptom severe symptoms student Surveillance tested Testing vaccination Vaccination Status Viral load [DOI] 10.3390/v14061198 PMC 바로가기 [Article Type] Article